LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
3.860
-0.100 (-2.53%)
At close: Sep 29, 2026, 4:00 PM EDT
3.900
+0.040 (1.04%)
After-hours: Sep 29, 2026, 7:30 PM EDT
LENZ Therapeutics Market Cap
LENZ Therapeutics has a market cap or net worth of $121.28 million as of September 29, 2026. Its market cap has decreased by -89.88% in one year.
Market Cap
121.28M
Enterprise Value
-98.15M
1-Year Change
-89.88%
Ranking
Category
Stock Price
$3.86
ChartMarket Cap Chart
Since March 22, 2024, LENZ Therapeutics's market cap has decreased from $413.64M to $121.28M, a decrease of -70.68%. That is a compound annual growth rate of -38.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2026 | 121.28M | -75.77% |
| Dec 31, 2025 | 500.64M | -36.94% |
| Dec 31, 2024 | 793.95M | 91.94% |
| Mar 22, 2024 | 413.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nautilus Biotechnology | 129.79M |
| Kazia Therapeutics | 129.02M |
| NRx Pharmaceuticals | 128.06M |
| enGene Therapeutics | 128.00M |
| Unicycive Therapeutics | 127.58M |
| Neumora Therapeutics | 126.12M |
| Tiziana Life Sciences | 124.14M |
| Inovio Pharmaceuticals | 118.91M |